Is Intramuscular Administration of Recombinant Human C1-Inhibitor an Alternative for the Treatment of Acute Attacks in Patients with Hereditary Angioedema?

被引：0
|
作者：
Staevska, Maria [1 ]
Valerieva, Anna [1 ]
机构：
[1] Med Univ Sofia, Clin Allergy & Asthma, Sofia, Bulgaria
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2017.12.187
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
185
引用
收藏
页码：AB58 / AB58
页数：1
相关论文
共 50 条
  • [41] Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy
    Lumry, William
    Templeton, Teri
    Omert, Laurel
    Levy, Donald
    JOURNAL OF INFUSION NURSING, 2020, 43 (03) : 134 - 145
  • [42] A RANDOMIZED TRIAL OF SUBCUTANEOUS C1-INHIBITOR FOR THE PREVENTION OF HEREDITARY ANGIOEDEMA ATTACKS
    Zuraw, B.
    Craig, T.
    Cicardi, M.
    Longhurst, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S1 - S1
  • [43] Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema
    Riedl, Marc A.
    Lumry, William R.
    Li, H. Henry
    Banerji, Aleena
    Bernstein, Jonathan A.
    Bas, Murat
    Bjorkander, Janne
    Magerl, Markus
    Maurer, Marcus
    Rockich, Kevin
    Chen, Hongzi
    Schranz, Jennifer
    ALLERGY AND ASTHMA PROCEEDINGS, 2016, 37 (06) : 489 - 500
  • [44] Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
    Nóra Veszeli
    Dorottya Csuka
    Zsuzsanna Zotter
    Éva Imreh
    Mihály Józsi
    Szabolcs Benedek
    Lilian Varga
    Henriette Farkas
    Orphanet Journal of Rare Diseases, 10
  • [45] Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
    Veszeli, Nora
    Csuka, Dorottya
    Zotter, Zsuzsanna
    Imreh, Eva
    Jozsi, Mihaly
    Benedek, Szabolcs
    Varga, Lilian
    Farkas, Henriette
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [46] C1-INHIBITOR FUNCTION AS A MARKER FOR HEREDITARY ANGIOEDEMA ACTIVITY IN PATIENTS ON SUBCUTANEOUS C1-INHIBITOR
    Levy, D.
    Riedl, M.
    Craig, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S90 - S90
  • [47] Functional C1-inhibitor level increases during attacks of hereditary angioedema
    Varga, Lilian A.
    Csuka, Dorottya
    Fust, George
    Zotter, Zsuzsanna
    Szabo, Erika
    Czaller, Ibolya
    Farkas, Henriette
    IMMUNOBIOLOGY, 2012, 217 (11) : 1172 - 1173
  • [48] Clinical Outcomes With Recombinant Human C1 Inhibitor In The Repeat Treatment Of Acute Attacks Of Hereditary Angioedema In North-american Patients
    Zuraw, B.
    Craig, T.
    Lockey, R. F.
    Park, M.
    Grant, J.
    Suez, D.
    Schwartz, L. B.
    Riedl, M.
    Levy, R. J.
    Li, H. H.
    Edara, L.
    Bernstein, J. A.
    Moy, J.
    Offenberger, J.
    Szema, A.
    Engler, A.
    Rehman, S. M.
    Marbury, T. C.
    Alpan, O.
    Bahna, S. L.
    Davis, A.
    Sussman, G.
    Yang, W. H.
    Ritchie, B.
    Relan, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB101 - AB101
  • [49] Long-term prophylaxis with recombinant human c1 inhibitor in patients with hereditary angioedema: Extended experience with intramuscular administration
    Valerieva, A.
    Krusheva, B.
    Staevska, M.
    ALLERGY, 2018, 73 : 726 - 726
  • [50] The presence and frequency of IgM type antibodies to C1-inhibitor are not related to the administration of C1-inhibitor concentrate in patients with hereditary angioedema
    Farkas, H.
    Varga, L.
    Csuka, D.
    Zotter, Z.
    Fust, G.
    ALLERGY, 2010, 65 : 443 - 443
12345